Renibus Therapeutics’ COVID-19 Treatment, RBT-9, Shows Antiviral Activity Against SARS-CoV-2 In Vitro

    NEXT STORY
    CRISPR Therapeutics Congratulates Co-Founder Emmanuelle Charpentier on Receiving the 2020 Nobel Prize in Chemistry
    PREV STORY
    NuGenerex Immuno-Oncology Announces Closing of a Licensing & Distribution Agreement with Bintai Kinden to Advance the Clinical Development & Commercialization of Ii-Key-SARS-CoV-2 Coronavirus Vaccine for Global Markets
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Intuitive Provides Update on Supporting Customers, Communities & Employees during COVID-19

    author_avatar
    NASDAQ Market News

    Affimed Reports Financial Results for First Quarter 2018

    Heidelberg, Germany, May 15, 2018 - Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical ...

    author_avatar
    NASDAQ Market News

    Helsinn supported ‘70 Years of Cancer Care in China’ celebratory event in Shanghai

    author_avatar
    NASDAQ Market News